Clinical Trials
6 trialsNCT05065411 2024-02-26
VERU-024
Veru Inc.
Phase 3 Terminated
NCT00543127 2023-03-10
Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole
Spanish Breast Cancer Research Group
Phase 3 Terminated
NCT02340221 2022-07-12
SANDPIPER
Hoffmann-La Roche
Phase 3 Terminated
NCT02137837 2021-01-28
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer
SWOG Cancer Research Network
Phase 3 Terminated
NCT01633060 2019-01-30
BELLE-3
Novartis
Phase 3 Terminated
NCT00010153 2012-07-19
ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated